pyrrolidonecarboxylic acid has been researched along with Ischemic Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boltze, J; Chu, CY; Gao, P; Geng, X; Lan, XY; Li, S; Qin, HM; Sun, ZW; Xu, GL | 1 |
| Callegari, E; Feng, S; Liu, Y; Mammenga, E; Min, JW; Qiao, F; Subedi, K; Wang, H | 1 |
2 other study(ies) available for pyrrolidonecarboxylic acid and Ischemic Stroke
| Article | Year |
|---|---|
Bone Marrow Mesenchymal Stem Cells Exert Protective Effects After Ischemic Stroke Through Upregulation of Glutathione.
Topics: Animals; Bone Marrow Cells; Glutathione; Humans; Infarction, Middle Cerebral Artery; Ischemic Stroke; Mesenchymal Stem Cells; Pyrrolidonecarboxylic Acid; Rats; Stroke; Up-Regulation | 2022 |
Therapeutic Role of a Cysteine Precursor, OTC, in Ischemic Stroke Is Mediated by Improved Proteostasis in Mice.
Topics: Adaptor Proteins, Signal Transducing; Animals; Autophagy-Related Proteins; Brain Ischemia; Cells, Cultured; Cysteine; Ischemic Stroke; Male; Mice, Inbred C57BL; Neurons; Oxidative Stress; Proteostasis; Pyrrolidonecarboxylic Acid; Thiazolidines | 2020 |